RxDoctor Payments Data

Henry Chu, MD

Interventional Cardiology · Vancouver, WANPI 1023389061

Payments from drug & device makers

$1,623in general payments, 2019–2025

Across 26 payments — averaging $62.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$798
  • Boston Scientific$598
  • Abiomed$93
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$80
  • Shockwave Medical, Inc$35
  • Edwards Lifesciences$19

What the payments were for

  • Grants$1006%
  • Food & beverage$1,44789%
  • Education$765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,623 in reported general payments places this provider in the 30th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$105,204
Medicare patients
261
Services billed
1,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban240$326,386
EntrestoSacubitril/Valsartan41$63,070
Repatha SureclickEvolocumab42$38,805
Repatha PushtronexEvolocumab33$23,856
XareltoRivaroxaban12$17,053
BrilintaTicagrelor11$12,814
Ethacrynic Acid11$11,340
VascepaIcosapent Ethyl15$8,595
Praluent PenAlirocumab12$6,247
Metoprolol Succinate329$4,143
Atorvastatin Calcium341$3,678
Ranolazine ErRanolazine41$3,552
ClopidogrelClopidogrel Bisulfate180$2,489
Rosuvastatin Calcium122$2,230
Isosorbide Mononitrate ErIsosorbide Mononitrate105$1,872

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →